Edwards Lifesciences (EW) Intangibles (2009 - 2026)

Edwards Lifesciences' Intangibles history runs 18 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Intangibles rose 4.51% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 4.51% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 4.11% from the prior year.
• Intangibles climbed to $1.2 billion in Q1 2026 per EW's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Intangibles topped out at $1.2 billion in Q1 2026 and bottomed at $266.5 million in Q3 2022.
• The 5-year median for Intangibles is $446.8 million (2023), against an average of $690.2 million.
• Across the five-year window, Intangibles retreated 18.08% in 2022 and jumped 194.59% in 2024, its largest moves.
• Year by year, Intangibles stood at $285.2 million in 2022, then soared by 40.04% to $399.4 million in 2023, then soared by 194.59% to $1.2 billion in 2024, then decreased by 4.11% to $1.1 billion in 2025, then rose by 8.84% to $1.2 billion in 2026.
• Per Business Quant, the three latest EW Intangibles figures stand at $1.2 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).